左乙拉西坦与奥卡西平治疗成人癫痫发作的 疗效比较
Comparison of the Efficacy of Levetiracetam and Oxcarbazepine in the Treatment of Adult Seizures
DOI: 10.12677/acm.2026.1631099, PDF,   
作者: 齐江彤:中国人民武装警察部队海警总队医院,神经内科,浙江 嘉兴
关键词: 左乙拉西坦奥卡西平癫痫Levetiracetam Oxcarbazepine Epilepsy
摘要: 目的:观察左乙拉西坦与奥卡西平在治疗成人癫痫发作方面的疗效有无明显差异,进而指导治疗方案的选择。方法:选择癫痫患者87例,分为奥卡西平组52例,左乙拉西坦组35例。结果:奥卡西平组52例患者中,控制32例,显效8例,有效6例,无效6例,总有效率为88.47%;左乙拉西坦组35例患者中,控制21例,显效5例,有效5例,无效4例,总有效率为88.58%;两组患者在有效率上无明显差异。
Abstract: Objective: To observe whether there is a significant difference in the efficacy of levetiracetam and oxcarbazepine in the treatment of adult epileptic seizures, and to guide the selection of treatment regimen. Method: 87 patients with epilepsy were selected and divided into an oxcarbazepine group (52 cases) and a levetiracetam group (35 cases). Conclusion: Among the 52 patients in the oxcarbazepine group, 32 were controlled, 8 showed significant efficacy, 6 were effective, and 6 were ineffective, with a total effective rate of 88.47%; among the 35 patients in the levetiracetam group, 21 were controlled, 5 showed significant efficacy, 5 were effective, and 4 were ineffective, with a total effective rate of 88.58%; there was no significant difference in the effective rate between the two groups.
文章引用:齐江彤. 左乙拉西坦与奥卡西平治疗成人癫痫发作的 疗效比较[J]. 临床医学进展, 2026, 16(3): 2959-2963. https://doi.org/10.12677/acm.2026.1631099

参考文献

[1] Panayiotopoulos, C.P. (2005) The Epilepsies: Seizures, Syndromes and Management: Based on the ILAE Classifications and Practice Parameter Guidelines. Bladon Medical Publishing.
[2] 张军, 谢庆荣, 等. 抗癫痫新药-奥卡西平[J]. 国外医学神经病学神经外科学分册, 1996, 23(1): 38.
[3] Dogan, E.A., Usta, B.E., Bilgen, R., Senol, Y. and Aktekin, B. (2008) Efficacy, Tolerability, and Side Effects of Oxcarbazepine Monotherapy: A Prospective Study in Adult and Elderly Patients with Newly Diagnosed Partial Epilepsy. Epilepsy & Behavior, 13, 156-161. [Google Scholar] [CrossRef] [PubMed]
[4] 侯国勇, 郑文泉, 赵文燕, 等. 奥卡西平治疗癫痫患者22例临床分析[J]. 中国医药指南, 2011, 9(55): 365-366.
[5] 曾凡明. 奥卡西平治疗癫痫的临床效果观察[J]. 中国医药指南, 2011, 9(1): 16-19.
[6] 何军, 何爱南. 难治性癫痫病30例临床分析[J]. 中国基层医药, 1999, 6(3): 185-186.
[7] Martinez, W., Ingenito, A., Blakeslee, M., Barkley, G.L., McCague, K. and D’Souza, J. (2006) Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy. Epilepsy & Behavior, 9, 448-456. [Google Scholar] [CrossRef] [PubMed]
[8] 田国红, 赵中新. 左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J]. 中国新药和临床杂志, 2006, 25(10): 782-786.
[9] Shorvon, S.D., Löwenthal, A., Janz, D., Bielen, E. and Loiseau, P. (2000) Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures. Epilepsia, 41, 1179-1186. [Google Scholar] [CrossRef] [PubMed]
[10] Kuba, R., Novotna, I., Brazdil, M., et al. (2010) Long-Term Levetiracetam Treatment in Patients with Epilepsy: 3-Year Follow up. Acta Neurologica Scandinavica, 121, 83-88. [Google Scholar] [CrossRef] [PubMed]
[11] Halma, E., de Louw, A.J.A., Klinkenberg, S., Aldenkamp, A.P., IJff, D.M. and Majoie, M. (2014) Behavioral Side-Effects of Levetiracetam in Children with Epilepsy: A Systematic Review. Seizure, 23, 685-691. [Google Scholar] [CrossRef] [PubMed]
[12] 刘伟, 蔡兴秋. 左乙拉西坦单药或添加治疗癫痫的临床观察[J]. 临床神经病学杂志, 2012, 25(3): 227-230.
[13] 朱军, 叶兴荣, 王爱茹, 陈小华, 顾卫霞, 庄志清. 奥卡西平与左乙拉西坦治疗新诊断部分性发作癫痫患儿的疗效分析[J]. 安徽医学, 2011, 33(11): 1468-1471.